Home > Press Releases > AI-based Pathology Market

AI-based Pathology Market Likely to Surpass USD 0.8 Billion by 2035

Report Code: HC-34567 | Published in: Jul 2026, By MarketGenics | Number of pages: 320

Global AI-based Pathology Market Forecast 2035:

According to the report, the global AI-based pathology market is likely to grow from USD 0.1 Billion in 2025 to USD 0.8 Billion in 2035 at a highest CAGR of 21.6% during the time period. The AI-based Pathology market is growing rapidly because of the growing adoption of digital pathology, the rise in the number of cancer cases worldwide, and the demand for quicker and more accurate diagnosis. AI-enabled pathology platforms are proving to be a valuable investment for improving workflow efficiency, minimizing diagnostic deviation and enabling precision oncology with automated tissue analysis and biomarker detection.

The rapid adoption of whole-slide imaging, computational pathology, cloud image management, and multimodal AI, which combine pathology with genomic and clinical information, are further driving the adoption of whole-slide imaging. Amid increasing shortages of pathologists, labs have been increasing their use of AI-powered diagnostic tools that boost productivity while improving the diagnostic quality of the path.With pathologists in short supply, labs are deploying AI-powered diagnostic tools that help boost productivity without sacrificing diagnostic quality.

Moreover, the growing regulatory approvals are boosting market growth and parallelly, emerging opportunities in the precision medicine and pharmaceutical collaborations for companion diagnostics are also driving the expansion of the market. The continuous evolution of innovative solutions from AI-first pathology software and digital laboratory solution providers is driving clinical adoption in hospitals, diagnostic labs and cancer centers globally.

Strong long-term market growth is expected as the field of pathology becomes more efficient and precise at diagnosis, thanks to AI advancements.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global AI-based Pathology Market”

The growing shortage of trained pathologists, coupled with increasing diagnostic workloads, is driving the adoption of AI-based pathology solutions. AI helps the experts to automate routine slide analysis, prioritize the complex cases and make the reporting process more efficient, but it does not replace their clinical expertise.

However, the interoperability of whole-slide imaging systems, laboratory information systems (LIS), hospital information systems (HIS), and AI software solutions remains a challenge in the adoption of AI-based pathology. The complexity of integrating data seamlessly between different image formats, vendor-specific architectures, and data exchange protocols makes the implementation more challenging and costly for healthcare providers.

AI-powered pathology is now being increasingly adopted by pharmaceutical and biotechnology firms for enhancing biomarker discovery, patient stratification, and the evaluation of treatment response during clinical trials. AI technology applications to tissue analysis can help to improve the ability to identify eligible patients more quickly and to ensure more efficient creation of targeted therapies, which can generate significant commercial potential for AI pathology solution providers.

Regional Analysis of Global AI-based Pathology Market

North America records the highest demand for AI-based Pathology due to the widespread deployment of enterprise digital pathology networks, strong adoption of cloud-based laboratory platforms, and extensive use of AI in oncology diagnostics. Healthcare institutions, pharmaceutical firms, and technology innovators in the region are well connected to speed up the precision medicine programs.
The Asia Pacific region is experiencing growth at a fast pace, as investments in digital healthcare infrastructure develop, with rising cancer screening programs and modernization of pathology laboratories in the region. AI-powered pathology is being used in countries like Japan, South Korea, India, and China to enhance diagnostic availability, tackle the challenge of pathologists' scarcity, and facilitate high-volume lab workflow.
Digital pathology is gaining traction in Europe where there is continued expansion both within public health systems and the expansion of precision oncology programs. Collaborative research projects between universities and the private sector in the field of cancer, digital innovation and the use of AI in the diagnosis of diseases by university hospitals and reference laboratories are encouraging more widespread implementation of AI-based solutions for pathology.

Prominent players operating in the global AI-based Pathology market such as Aiforia Technologies Plc, F. Hoffmann-La Roche Ltd., Hamamatsu Photonics K.K., Hologic, Inc., Indica Labs, Inc., Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH, Nucleai Ltd., PathAI, Inc., Proscia Inc., Siemens Healthineers AG, Tempus AI, Inc., Visiopharm A/S, Other Key Players.

The global AI-based pathology market has been segmented as follows:

Global AI-based Pathology Market Analysis, by Component

Software
- Digital Pathology Software
- AI Image Analysis Software
- Whole Slide Imaging (WSI) Software
- Clinical Decision Support Software
- Laboratory Information Management System (LIMS) Software
- Workflow Management Software
- Analytics & Reporting Software
- Cloud-Based Pathology Platforms
- Others
Hardware
- Whole Slide Scanners
- Digital Microscopes
- AI Servers & Workstations
- High-Performance Computing (HPC) Systems
- Data Storage Systems
- Imaging Cameras
- Display & Visualization Systems
- Networking & Connectivity Devices
- Others
Services
- Consulting Services
- System Integration & Deployment Services
- AI Development & Customization Services
- Cloud & Managed Services
- Technical Support & Maintenance
- Training & Education Services
- Data Management Services
- Regulatory & Compliance Services
- Others

Global AI-based Pathology Market Analysis, by Technology

Machine Learning (ML)
Deep Learning
Computer Vision
Natural Language Processing (NLP)
Generative AI
Predictive Analytics
Image Analysis Algorithms
Cloud Computing
Others

Global AI-based Pathology Market Analysis, by Deployment Mode

Cloud-Based
On-Premises
Hybrid

Global AI-based Pathology Market Analysis, by Pathology Type

Anatomical Pathology
Clinical Pathology
Molecular Pathology
Digital Pathology
Forensic Pathology
Hematopathology
Cytopathology
Histopathology
Others

Global AI-based Pathology Market Analysis, by Imaging Modality

Whole Slide Imaging (WSI)
Brightfield Imaging
Fluorescence Imaging
Immunohistochemistry (IHC) Imaging
Digital Microscopy
Multiplex Imaging
Cytology Imaging
Others

Global AI-based Pathology Market Analysis, by Disease Area

Oncology
Infectious Diseases
Neurology
Cardiology
Dermatology
Gastroenterology
Nephrology
Hematological Disorders
Others

Global AI-based Pathology Market Analysis, by Application

Cancer Diagnosis
Disease Detection & Classification
Biomarker Discovery
Drug Discovery & Development
Companion Diagnostics
Laboratory Workflow Automation
Clinical Decision Support
Research & Education
Quality Control & Assurance
Others

Global AI-based Pathology Market Analysis, by End User

Hospitals
Diagnostic Laboratories
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Reference Laboratories
Cancer Research Centers
Specialty Clinics
Others

Global AI-based Pathology Market Analysis, by Region

North America
Europe
Asia Pacific
Middle East
Africa
South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact US

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
  - 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
  - 1.6.1. Open Sources
  - 1.6.2. Paid Databases
  - 1.6.3. Associations
- 1.7. Primary Research
  - 1.7.1. Primary Sources
  - 1.7.2. Primary Interviews with Stakeholders across Ecosystem
2. Executive Summary
- 2.1. Global AI-based Pathology Market Outlook
  - 2.1.1. AI-based Pathology Market Size (Value - US$ Bn), and Forecasts, 2021-2035
  - 2.1.2. Compounded Annual Growth Rate Analysis
  - 2.1.3. Growth Opportunity Analysis
  - 2.1.4. Segmental Share Analysis
  - 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
  - 2.5.1. Customer/ End-use Industry Assessment
  - 2.5.2. Growth Opportunity Data, 2026-2035
    - 2.5.2.1. Regional Data
    - 2.5.2.2. Country Data
    - 2.5.2.3. Segmental Data
  - 2.5.3. Identification of Potential Market Spaces
  - 2.5.4. GAP Analysis
  - 2.5.5. Potential Attractive Price Points
  - 2.5.6. Prevailing Market Risks & Challenges
  - 2.5.7. Preferred Sales & Marketing Strategies
  - 2.5.8. Key Recommendations and Analysis
  - 2.5.9. A Way Forward
3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
  - 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
  - 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
  - 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
4. Market Overview
- 4.1. Market Dynamics
  - 4.1.1. Drivers
    - 4.1.1.1. Rising demand for faster and more accurate diagnostic workflows
    - 4.1.1.2. Growing adoption of digital pathology and AI-powered image analysis
    - 4.1.1.3. Increasing prevalence of cancer and chronic diseases requiring precise diagnostics.
  - 4.1.2. Restraints
    - 4.1.2.1. High implementation and integration costs of AI pathology platforms
    - 4.1.2.2. Data privacy concerns and stringent regulatory approval requirements.
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
  - 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
  - 4.3.2. Tariffs and Standards
  - 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Ecosystem Analysis
- 4.5. Porter’s Five Forces Analysis
- 4.6. PESTEL Analysis
- 4.7. Global AI-based Pathology Market Demand
  - 4.7.1. Historical Market Size – in Value (US$ Bn), 2020-2024
  - 4.7.2. Current and Future Market Size – in Value (US$ Bn), 2026–2035
    - 4.7.2.1. Y-o-Y Growth Trends
    - 4.7.2.2. Absolute $ Opportunity Assessment
5. Competition Landscape
- 5.1. Competition structure
  - 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
  - 5.2.1. Global Company Market Share
  - 5.2.2. By Region
    - 5.2.2.1. North America
    - 5.2.2.2. Europe
    - 5.2.2.3. Asia Pacific
    - 5.2.2.4. Middle East
    - 5.2.2.5. Africa
    - 5.2.2.6. South America
- 5.3. Product Comparison Matrix
  - 5.3.1. Specifications
  - 5.3.2. Market Positioning
  - 5.3.3. Pricing
6. Global AI-based Pathology Market Analysis, by Component
- 6.1. Key Segment Analysis
- 6.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Component, 2021-2035
  - 6.2.1. Software
    - 6.2.1.1. Digital Pathology Software
    - 6.2.1.2. AI Image Analysis Software
    - 6.2.1.3. Whole Slide Imaging (WSI) Software
    - 6.2.1.4. Clinical Decision Support Software
    - 6.2.1.5. Laboratory Information Management System (LIMS) Software
    - 6.2.1.6. Workflow Management Software
    - 6.2.1.7. Analytics & Reporting Software
    - 6.2.1.8. Cloud-Based Pathology Platforms
    - 6.2.1.9. Others
  - 6.2.2. Hardware
    - 6.2.2.1. Whole Slide Scanners
    - 6.2.2.2. Digital Microscopes
    - 6.2.2.3. AI Servers & Workstations
    - 6.2.2.4. High-Performance Computing (HPC) Systems
    - 6.2.2.5. Data Storage Systems
    - 6.2.2.6. Imaging Cameras
    - 6.2.2.7. Display & Visualization Systems
    - 6.2.2.8. Networking & Connectivity Devices
    - 6.2.2.9. Others
  - 6.2.3. Services
    - 6.2.3.1. Consulting Services
    - 6.2.3.2. System Integration & Deployment Services
    - 6.2.3.3. AI Development & Customization Services
    - 6.2.3.4. Cloud & Managed Services
    - 6.2.3.5. Technical Support & Maintenance
    - 6.2.3.6. Training & Education Services
    - 6.2.3.7. Data Management Services
    - 6.2.3.8. Regulatory & Compliance Services
    - 6.2.3.9. Others
7. Global AI-based Pathology Market Analysis, by Technology
- 7.1. Key Segment Analysis
- 7.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
  - 7.2.1. Machine Learning (ML)
  - 7.2.2. Deep Learning
  - 7.2.3. Computer Vision
  - 7.2.4. Natural Language Processing (NLP)
  - 7.2.5. Generative AI
  - 7.2.6. Predictive Analytics
  - 7.2.7. Image Analysis Algorithms
  - 7.2.8. Cloud Computing
  - 7.2.9. Others
8. Global AI-based Pathology Market Analysis, by Deployment Mode
- 8.1. Key Segment Analysis
- 8.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
  - 8.2.1. Cloud-Based
  - 8.2.2. On-Premises
  - 8.2.3. Hybrid
9. Global AI-based Pathology Market Analysis, by Pathology Type
- 9.1. Key Segment Analysis
- 9.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Pathology Type, 2021-2035
  - 9.2.1. Anatomical Pathology
  - 9.2.2. Clinical Pathology
  - 9.2.3. Molecular Pathology
  - 9.2.4. Digital Pathology
  - 9.2.5. Forensic Pathology
  - 9.2.6. Hematopathology
  - 9.2.7. Cytopathology
  - 9.2.8. Histopathology
  - 9.2.9. Others
10. Global AI-based Pathology Market Analysis, by Imaging Modality
- 10.1. Key Segment Analysis
- 10.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Imaging Modality, 2021-2035
  - 10.2.1. Whole Slide Imaging (WSI)
  - 10.2.2. Brightfield Imaging
  - 10.2.3. Fluorescence Imaging
  - 10.2.4. Immunohistochemistry (IHC) Imaging
  - 10.2.5. Digital Microscopy
  - 10.2.6. Multiplex Imaging
  - 10.2.7. Cytology Imaging
  - 10.2.8. Others
11. Global AI-based Pathology Market Analysis, by Disease Area
- 11.1. Key Segment Analysis
- 11.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Disease Area, 2021-2035
  - 11.2.1. Oncology
  - 11.2.2. Infectious Diseases
  - 11.2.3. Neurology
  - 11.2.4. Cardiology
  - 11.2.5. Dermatology
  - 11.2.6. Gastroenterology
  - 11.2.7. Nephrology
  - 11.2.8. Hematological Disorders
  - 11.2.9. Others
12. Global AI-based Pathology Market Analysis, by Application
- 12.1. Key Segment Analysis
- 12.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
  - 12.2.1. Cancer Diagnosis
  - 12.2.2. Disease Detection & Classification
  - 12.2.3. Biomarker Discovery
  - 12.2.4. Drug Discovery & Development
  - 12.2.5. Companion Diagnostics
  - 12.2.6. Laboratory Workflow Automation
  - 12.2.7. Clinical Decision Support
  - 12.2.8. Research & Education
  - 12.2.9. Quality Control & Assurance
  - 12.2.10. Others
13. Global AI-based Pathology Market Analysis, by End User
- 13.1. Key Segment Analysis
- 13.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
  - 13.2.1. Hospitals
  - 13.2.2. Diagnostic Laboratories
  - 13.2.3. Academic & Research Institutes
  - 13.2.4. Pharmaceutical & Biotechnology Companies
  - 13.2.5. Contract Research Organizations (CROs)
  - 13.2.6. Reference Laboratories
  - 13.2.7. Cancer Research Centers
  - 13.2.8. Specialty Clinics
  - 13.2.9. Others
14. Global AI-based Pathology Market Analysis, by Region
- 14.1. Key Findings
- 14.2. AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
  - 14.2.1. North America
  - 14.2.2. Europe
  - 14.2.3. Asia Pacific
  - 14.2.4. Middle East
  - 14.2.5. Africa
  - 14.2.6. South America
15. North America AI-based Pathology Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. North America AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 15.3.1. Component
  - 15.3.2. Technology
  - 15.3.3. Deployment Mode
  - 15.3.4. Pathology Type
  - 15.3.5. Imaging Modality
  - 15.3.6. Disease Area
  - 15.3.7. Application
  - 15.3.8. End User
  - 15.3.9. Country
    - 15.3.9.1. USA
    - 15.3.9.2. Canada
    - 15.3.9.3. Mexico
- 15.4. USA AI-based Pathology Market
  - 15.4.1. Country Segmental Analysis
  - 15.4.2. Component
  - 15.4.3. Technology
  - 15.4.4. Deployment Mode
  - 15.4.5. Pathology Type
  - 15.4.6. Imaging Modality
  - 15.4.7. Disease Area
  - 15.4.8. Application
  - 15.4.9. End User
- 15.5. Canada AI-based Pathology Market
  - 15.5.1. Country Segmental Analysis
  - 15.5.2. Component
  - 15.5.3. Technology
  - 15.5.4. Deployment Mode
  - 15.5.5. Pathology Type
  - 15.5.6. Imaging Modality
  - 15.5.7. Disease Area
  - 15.5.8. Application
  - 15.5.9. End User
- 15.6. Mexico AI-based Pathology Market
  - 15.6.1. Country Segmental Analysis
  - 15.6.2. Component
  - 15.6.3. Technology
  - 15.6.4. Deployment Mode
  - 15.6.5. Pathology Type
  - 15.6.6. Imaging Modality
  - 15.6.7. Disease Area
  - 15.6.8. Application
  - 15.6.9. End User
16. Europe AI-based Pathology Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Europe AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 16.3.1. Component
  - 16.3.2. Technology
  - 16.3.3. Deployment Mode
  - 16.3.4. Pathology Type
  - 16.3.5. Imaging Modality
  - 16.3.6. Disease Area
  - 16.3.7. Application
  - 16.3.8. End User
  - 16.3.9. Country
    - 16.3.9.1. Germany
    - 16.3.9.2. United Kingdom
    - 16.3.9.3. France
    - 16.3.9.4. Italy
    - 16.3.9.5. Spain
    - 16.3.9.6. Netherlands
    - 16.3.9.7. Nordic Countries
    - 16.3.9.8. Poland
    - 16.3.9.9. Russia & CIS
    - 16.3.9.10. Rest of Europe
- 16.4. Germany AI-based Pathology Market
  - 16.4.1. Country Segmental Analysis
  - 16.4.2. Component
  - 16.4.3. Technology
  - 16.4.4. Deployment Mode
  - 16.4.5. Pathology Type
  - 16.4.6. Imaging Modality
  - 16.4.7. Disease Area
  - 16.4.8. Application
  - 16.4.9. End User
- 16.5. United Kingdom AI-based Pathology Market
  - 16.5.1. Country Segmental Analysis
  - 16.5.2. Component
  - 16.5.3. Technology
  - 16.5.4. Deployment Mode
  - 16.5.5. Pathology Type
  - 16.5.6. Imaging Modality
  - 16.5.7. Disease Area
  - 16.5.8. Application
  - 16.5.9. End User
- 16.6. France AI-based Pathology Market
  - 16.6.1. Country Segmental Analysis
  - 16.6.2. Component
  - 16.6.3. Technology
  - 16.6.4. Deployment Mode
  - 16.6.5. Pathology Type
  - 16.6.6. Imaging Modality
  - 16.6.7. Disease Area
  - 16.6.8. Application
  - 16.6.9. End User
- 16.7. Italy AI-based Pathology Market
  - 16.7.1. Country Segmental Analysis
  - 16.7.2. Component
  - 16.7.3. Technology
  - 16.7.4. Deployment Mode
  - 16.7.5. Pathology Type
  - 16.7.6. Imaging Modality
  - 16.7.7. Disease Area
  - 16.7.8. Application
  - 16.7.9. End User
- 16.8. Spain AI-based Pathology Market
  - 16.8.1. Country Segmental Analysis
  - 16.8.2. Component
  - 16.8.3. Technology
  - 16.8.4. Deployment Mode
  - 16.8.5. Pathology Type
  - 16.8.6. Imaging Modality
  - 16.8.7. Disease Area
  - 16.8.8. Application
  - 16.8.9. End User
- 16.9. Netherlands AI-based Pathology Market
  - 16.9.1. Country Segmental Analysis
  - 16.9.2. Component
  - 16.9.3. Technology
  - 16.9.4. Deployment Mode
  - 16.9.5. Pathology Type
  - 16.9.6. Imaging Modality
  - 16.9.7. Disease Area
  - 16.9.8. Application
  - 16.9.9. End User
- 16.10. Nordic Countries AI-based Pathology Market
  - 16.10.1. Country Segmental Analysis
  - 16.10.2. Component
  - 16.10.3. Technology
  - 16.10.4. Deployment Mode
  - 16.10.5. Pathology Type
  - 16.10.6. Imaging Modality
  - 16.10.7. Disease Area
  - 16.10.8. Application
  - 16.10.9. End User
- 16.11. Poland AI-based Pathology Market
  - 16.11.1. Component
  - 16.11.2. Component
  - 16.11.3. Technology
  - 16.11.4. Deployment Mode
  - 16.11.5. Pathology Type
  - 16.11.6. Imaging Modality
  - 16.11.7. Disease Area
  - 16.11.8. Application
  - 16.11.9. End User
- 16.12. Russia & CIS AI-based Pathology Market
  - 16.12.1. Country Segmental Analysis
  - 16.12.2. Component
  - 16.12.3. Technology
  - 16.12.4. Deployment Mode
  - 16.12.5. Pathology Type
  - 16.12.6. Imaging Modality
  - 16.12.7. Disease Area
  - 16.12.8. Application
  - 16.12.9. End User
- 16.13. Rest of Europe AI-based Pathology Market
  - 16.13.1. Country Segmental Analysis
  - 16.13.2. Component
  - 16.13.3. Technology
  - 16.13.4. Deployment Mode
  - 16.13.5. Pathology Type
  - 16.13.6. Imaging Modality
  - 16.13.7. Disease Area
  - 16.13.8. Application
  - 16.13.9. End User
17. Asia Pacific AI-based Pathology Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Asia Pacific AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 17.3.1. Component
  - 17.3.2. Technology
  - 17.3.3. Deployment Mode
  - 17.3.4. Pathology Type
  - 17.3.5. Imaging Modality
  - 17.3.6. Disease Area
  - 17.3.7. Application
  - 17.3.8. End User
  - 17.3.9. Country
    - 17.3.9.1. China
    - 17.3.9.2. India
    - 17.3.9.3. Japan
    - 17.3.9.4. South Korea
    - 17.3.9.5. Australia and New Zealand
    - 17.3.9.6. Indonesia
    - 17.3.9.7. Malaysia
    - 17.3.9.8. Thailand
    - 17.3.9.9. Vietnam
    - 17.3.9.10. Rest of Asia Pacific
- 17.4. China AI-based Pathology Market
  - 17.4.1. Country Segmental Analysis
  - 17.4.2. Component
  - 17.4.3. Technology
  - 17.4.4. Deployment Mode
  - 17.4.5. Pathology Type
  - 17.4.6. Imaging Modality
  - 17.4.7. Disease Area
  - 17.4.8. Application
  - 17.4.9. End User
- 17.5. India AI-based Pathology Market
  - 17.5.1. Country Segmental Analysis
  - 17.5.2. Component
  - 17.5.3. Technology
  - 17.5.4. Deployment Mode
  - 17.5.5. Pathology Type
  - 17.5.6. Imaging Modality
  - 17.5.7. Disease Area
  - 17.5.8. Application
  - 17.5.9. End User
- 17.6. Japan AI-based Pathology Market
  - 17.6.1. Country Segmental Analysis
  - 17.6.2. Component
  - 17.6.3. Technology
  - 17.6.4. Deployment Mode
  - 17.6.5. Pathology Type
  - 17.6.6. Imaging Modality
  - 17.6.7. Disease Area
  - 17.6.8. Application
  - 17.6.9. End User
- 17.7. South Korea AI-based Pathology Market
  - 17.7.1. Country Segmental Analysis
  - 17.7.2. Component
  - 17.7.3. Technology
  - 17.7.4. Deployment Mode
  - 17.7.5. Pathology Type
  - 17.7.6. Imaging Modality
  - 17.7.7. Disease Area
  - 17.7.8. Application
  - 17.7.9. End User
- 17.8. Australia and New Zealand AI-based Pathology Market
  - 17.8.1. Country Segmental Analysis
  - 17.8.2. Component
  - 17.8.3. Technology
  - 17.8.4. Deployment Mode
  - 17.8.5. Pathology Type
  - 17.8.6. Imaging Modality
  - 17.8.7. Disease Area
  - 17.8.8. Application
  - 17.8.9. End User
- 17.9. End User Indonesia AI-based Pathology Market
  - 17.9.1. Country Segmental Analysis
  - 17.9.2. Component
  - 17.9.3. Technology
  - 17.9.4. Deployment Mode
  - 17.9.5. Pathology Type
  - 17.9.6. Imaging Modality
  - 17.9.7. Disease Area
  - 17.9.8. Application
  - 17.9.9. End User
- 17.10. Malaysia AI-based Pathology Market
  - 17.10.1. Country Segmental Analysis
  - 17.10.2. Component
  - 17.10.3. Technology
  - 17.10.4. Deployment Mode
  - 17.10.5. Pathology Type
  - 17.10.6. Imaging Modality
  - 17.10.7. Disease Area
  - 17.10.8. Application
  - 17.10.9. End User
- 17.11. Thailand AI-based Pathology Market
  - 17.11.1. Country Segmental Analysis
  - 17.11.2. Component
  - 17.11.3. Technology
  - 17.11.4. Deployment Mode
  - 17.11.5. Pathology Type
  - 17.11.6. Imaging Modality
  - 17.11.7. Disease Area
  - 17.11.8. Application
  - 17.11.9. End User
- 17.12. Vietnam AI-based Pathology Market
  - 17.12.1. Country Segmental Analysis
  - 17.12.2. Component
  - 17.12.3. Technology
  - 17.12.4. Deployment Mode
  - 17.12.5. Pathology Type
  - 17.12.6. Imaging Modality
  - 17.12.7. Disease Area
  - 17.12.8. Application
  - 17.12.9. End User
- 17.13. Rest of Asia Pacific AI-based Pathology Market
  - 17.13.1. Country Segmental Analysis
  - 17.13.2. Component
  - 17.13.3. Technology
  - 17.13.4. Deployment Mode
  - 17.13.5. Pathology Type
  - 17.13.6. Imaging Modality
  - 17.13.7. Disease Area
  - 17.13.8. Application
  - 17.13.9. End User
18. Middle East AI-based Pathology Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Middle East AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 18.3.1. Component
  - 18.3.2. Technology
  - 18.3.3. Deployment Mode
  - 18.3.4. Pathology Type
  - 18.3.5. Imaging Modality
  - 18.3.6. Disease Area
  - 18.3.7. Application
  - 18.3.8. End User
  - 18.3.9. Country
    - 18.3.9.1. Turkey
    - 18.3.9.2. UAE
    - 18.3.9.3. Saudi Arabia
    - 18.3.9.4. Israel
    - 18.3.9.5. Rest of Middle East
- 18.4. Turkey AI-based Pathology Market
  - 18.4.1. Country Segmental Analysis
  - 18.4.2. Component
  - 18.4.3. Technology
  - 18.4.4. Deployment Mode
  - 18.4.5. Pathology Type
  - 18.4.6. Imaging Modality
  - 18.4.7. Disease Area
  - 18.4.8. Application
  - 18.4.9. End User
- 18.5. UAE AI-based Pathology Market
  - 18.5.1. Country Segmental Analysis
  - 18.5.2. Component
  - 18.5.3. Technology
  - 18.5.4. Deployment Mode
  - 18.5.5. Pathology Type
  - 18.5.6. Imaging Modality
  - 18.5.7. Disease Area
  - 18.5.8. Application
  - 18.5.9. End User
- 18.6. Saudi Arabia AI-based Pathology Market
  - 18.6.1. Country Segmental Analysis
  - 18.6.2. Component
  - 18.6.3. Technology
  - 18.6.4. Deployment Mode
  - 18.6.5. Pathology Type
  - 18.6.6. Imaging Modality
  - 18.6.7. Disease Area
  - 18.6.8. Application
  - 18.6.9. End User
- 18.7. Israel AI-based Pathology Market
  - 18.7.1. Country Segmental Analysis
  - 18.7.2. Component
  - 18.7.3. Technology
  - 18.7.4. Deployment Mode
  - 18.7.5. Pathology Type
  - 18.7.6. Imaging Modality
  - 18.7.7. Disease Area
  - 18.7.8. Application
  - 18.7.9. End User
- 18.8. Rest of Middle East AI-based Pathology Market
  - 18.8.1. Country Segmental Analysis
  - 18.8.2. Component
  - 18.8.3. Technology
  - 18.8.4. Deployment Mode
  - 18.8.5. Pathology Type
  - 18.8.6. Imaging Modality
  - 18.8.7. Disease Area
  - 18.8.8. Application
  - 18.8.9. End User
19. Africa AI-based Pathology Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Africa AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 19.3.1. Component
  - 19.3.2. Technology
  - 19.3.3. Deployment Mode
  - 19.3.4. Pathology Type
  - 19.3.5. Imaging Modality
  - 19.3.6. Disease Area
  - 19.3.7. Application
  - 19.3.8. End User
  - 19.3.9. Country
    - 19.3.9.1. South Africa
    - 19.3.9.2. Egypt
    - 19.3.9.3. Nigeria
    - 19.3.9.4. Algeria
    - 19.3.9.5. Rest of Africa
- 19.4. South Africa AI-based Pathology Market
  - 19.4.1. Country Segmental Analysis
  - 19.4.2. Component
  - 19.4.3. Technology
  - 19.4.4. Deployment Mode
  - 19.4.5. Pathology Type
  - 19.4.6. Imaging Modality
  - 19.4.7. Disease Area
  - 19.4.8. Application
  - 19.4.9. End User
- 19.5. Egypt AI-based Pathology Market
  - 19.5.1. Country Segmental Analysis
  - 19.5.2. Component
  - 19.5.3. Technology
  - 19.5.4. Deployment Mode
  - 19.5.5. Pathology Type
  - 19.5.6. Imaging Modality
  - 19.5.7. Disease Area
  - 19.5.8. Application
  - 19.5.9. End User
- 19.6. Nigeria AI-based Pathology Market
  - 19.6.1. Country Segmental Analysis
  - 19.6.2. Component
  - 19.6.3. Technology
  - 19.6.4. Deployment Mode
  - 19.6.5. Pathology Type
  - 19.6.6. Imaging Modality
  - 19.6.7. Disease Area
  - 19.6.8. Application
  - 19.6.9. End User
- 19.7. Algeria AI-based Pathology Market
  - 19.7.1. Country Segmental Analysis
  - 19.7.2. Component
  - 19.7.3. Technology
  - 19.7.4. Deployment Mode
  - 19.7.5. Pathology Type
  - 19.7.6. Imaging Modality
  - 19.7.7. Disease Area
  - 19.7.8. Application
  - 19.7.9. End User
- 19.8. Rest of Africa AI-based Pathology Market
  - 19.8.1. Country Segmental Analysis
  - 19.8.2. Component
  - 19.8.3. Technology
  - 19.8.4. Deployment Mode
  - 19.8.5. Pathology Type
  - 19.8.6. Imaging Modality
  - 19.8.7. Disease Area
  - 19.8.8. Application
  - 19.8.9. End User
20. South America AI-based Pathology Market Analysis
- 20.1. Key Segment Analysis
- 20.2. Regional Snapshot
- 20.3. South America AI-based Pathology Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 20.3.1. Component
  - 20.3.2. Technology
  - 20.3.3. Deployment Mode
  - 20.3.4. Pathology Type
  - 20.3.5. Imaging Modality
  - 20.3.6. Disease Area
  - 20.3.7. Application
  - 20.3.8. End User
  - 20.3.9. Country
    - 20.3.9.1. Brazil
    - 20.3.9.2. Argentina
    - 20.3.9.3. Rest of South America
- 20.4. Brazil AI-based Pathology Market
  - 20.4.1. Country Segmental Analysis
  - 20.4.2. Component
  - 20.4.3. Technology
  - 20.4.4. Deployment Mode
  - 20.4.5. Pathology Type
  - 20.4.6. Imaging Modality
  - 20.4.7. Disease Area
  - 20.4.8. Application
  - 20.4.9. End User
- 20.5. Argentina AI-based Pathology Market
  - 20.5.1. Country Segmental Analysis
  - 20.5.2. Component
  - 20.5.3. Technology
  - 20.5.4. Deployment Mode
  - 20.5.5. Pathology Type
  - 20.5.6. Imaging Modality
  - 20.5.7. Disease Area
  - 20.5.8. Application
  - 20.5.9. End User
- 20.6. Rest of South America AI-based Pathology Market
  - 20.6.1. Country Segmental Analysis
  - 20.6.2. Component
  - 20.6.3. Technology
  - 20.6.4. Deployment Mode
  - 20.6.5. Pathology Type
  - 20.6.6. Imaging Modality
  - 20.6.7. Disease Area
  - 20.6.8. Application
  - 20.6.9. End User
21. Key Players/ Company Profile
- 21.1. Aiforia Technologies Plc.
  - 21.1.1. Company Details/ Overview
  - 21.1.2. Company Financials
  - 21.1.3. Key Customers and Competitors
  - 21.1.4. Business/ Industry Portfolio
  - 21.1.5. Product Portfolio/ Specification Details
  - 21.1.6. Pricing Data
  - 21.1.7. Strategic Overview
  - 21.1.8. Recent Developments
- 21.2. F. Hoffmann-La Roche Ltd.
- 21.3. Hamamatsu Photonics K.K.
- 21.4. Hologic, Inc.
- 21.5. Indica Labs, Inc.
- 21.6. Koninklijke Philips N.V.
- 21.7. Leica Biosystems Nussloch GmbH
- 21.8. Nucleai Ltd.
- 21.9. PathAI, Inc.
- 21.10. Proscia Inc.
- 21.11. Siemens Healthineers AG
- 21.12. Tempus AI, Inc.
- 21.13. Visiopharm A/S
- 21.14. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF

PRICING DETAILS

Single-User Upto 2 Users - [PDF + Excel Only]

USD 4150

Multi-User Upto 10 Users - [PDF + Excel + PPT]

USD 5950

Enterprise-User Company-wide - [Report Pack + Benchmark + 6M Update]

USD 7750

Related Report

Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation